DOI:
10.1055/s-00000025
Hormone and Metabolic Research
LinksClose Window
References
Charbonnel B, Karasik A, Liu J, Wu M, Meininger G.
Efficacy and safety of the dipeptidyl peptidase-4 inhibitor sitagliptin added to ongoing metformin therapy in patients with type 2 diabetes inadequately controlled with metformin alone.
Diabetes Care 2006; 29: 2638-2643
We do not assume any responsibility for the contents of the web pages of other providers.